Balchem (NASDAQ:BCPC) Hits New 12-Month Low at $110.15

Balchem Co. (NASDAQ:BCPCGet Rating) hit a new 52-week low during trading on Tuesday . The stock traded as low as $110.15 and last traded at $116.67, with a volume of 150857 shares trading hands. The stock had previously closed at $114.59.

A number of research firms have weighed in on BCPC. began coverage on Balchem in a research note on Thursday, March 31st. They issued a “buy” rating for the company. HC Wainwright decreased their target price on shares of Balchem from $155.00 to $152.00 and set a “buy” rating for the company in a research note on Monday, May 2nd.

The firm has a market cap of $3.79 billion, a price-to-earnings ratio of 37.81 and a beta of 0.66. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.71 and a current ratio of 2.59. The firm has a fifty day simple moving average of $123.07 and a 200-day simple moving average of $138.99.

Balchem (NASDAQ:BCPCGet Rating) last released its quarterly earnings results on Friday, April 29th. The basic materials company reported $0.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.73 by $0.16. Balchem had a return on equity of 13.02% and a net margin of 12.07%. The business had revenue of $228.87 million during the quarter, compared to the consensus estimate of $211.00 million. During the same period in the previous year, the company posted $0.87 EPS. Analysts expect that Balchem Co. will post 3.46 earnings per share for the current fiscal year.

Institutional investors and hedge funds have recently modified their holdings of the company. Intelligent Financial Strategies acquired a new position in Balchem in the 4th quarter worth about $25,000. CWM LLC acquired a new stake in Balchem in the fourth quarter valued at $28,000. Quantbot Technologies LP bought a new position in Balchem during the 1st quarter worth $34,000. Captrust Financial Advisors lifted its holdings in Balchem by 195.4% during the 3rd quarter. Captrust Financial Advisors now owns 319 shares of the basic materials company’s stock worth $46,000 after buying an additional 211 shares during the period. Finally, UMB Bank N A MO bought a new stake in shares of Balchem in the 4th quarter valued at about $56,000. Institutional investors own 89.60% of the company’s stock.

Balchem Company Profile (NASDAQ:BCPC)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.

Featured Stories

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with's FREE daily email newsletter.